AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research-Reference-Cited by-同舟云学术

AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research

Published:2014-03-20 Issue:4 Volume:54 Page:1050-1060
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Liu Haibin¹²,Wang Lirong¹,Lv Mingliang²,Pei Rongrong²,Li Peibo²,Pei Zhong³,Wang Yonggang²,Su Weiwei²,Xie Xiang-Qun¹

Affiliation:

1. Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; Drug Discovery Institute; University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States

2. Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-Sen University, Guangzhou 510275, P.R. China

3. Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, P.R. China

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci500004h

Reference82 articles.

1. Alzheimer's Disease

2. The worldwide societal costs of dementia: Estimates for 2009

3. Pathways towards and away from Alzheimer's disease

4. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases

5. Advance in the pathogenesis and treatment of Wilson disease

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer’s disease pathologies;Experimental & Molecular Medicine;2024-09-02

2. Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease;European Journal of Medicinal Chemistry;2024-09

3. Three-Dimensional Quantitative Structure–Activity Relationship Study of Transient Receptor Potential Vanilloid 1 Channel Antagonists Reveals Potential for Drug Design Purposes;International Journal of Molecular Sciences;2024-07-21

4. Synthesis, in vitro activity, and molecular docking of caffeic acid and resveratrol derivatives against Alzheimer’s disease-related enzymes;Medicinal Chemistry Research;2024-07-19

5. Comparative Docking Strategies for Alzheimer’s Therapy: Exploring Drug and Phytocompound Interactions with BIN1 Protein;2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE);2024-05-14